ννλ‘λ©λ‘μ€μ€
ννλ‘λ©λ‘μ€μ€λ μΌμ€ λλ¬Όλ§μ μμ± μ±λΆμ λ체νκΈ° μν΄ μ¬μ©λλ μ λ£°λ‘μ€μ€ κΈ°λ°μ μμ± μΈκ³΅ λλ¬Όμ λλ€. λλ¬Ό λͺ¨λ°©μ λ‘ μμ©νμ¬ λμ μ€νμ μ 곡νκ³ κ±΄μ‘°ν¨μ μνν©λλ€. **μμ ν:** λλ¬Όμ κ±΄μ± κ°κ²°λ§μΌ(KCS, μꡬ건쑰μ¦) κ΄λ¦¬μ μμ£Ό μ¬μ©λλ©°, μ’ μ’ κ΅μ μ¬μ΄ν΄λ‘μ€ν¬λ¦°μ΄λ νν¬λ‘리무μ€μ κ°μ λλ¬Ό μκ·Ήμ μ ν¨κ» μ¬μ©λ©λλ€. μμ± λ체μ μ΄λ―λ‘ μ μ±μ΄ λμ μ°κ³ λ κ²μ λΉν΄ λ μμ£Ό μ μν΄μΌ ν©λλ€.
μμ© κΈ°μ : Hypromellose is a hydrophilic polymer that acts as a **lacrimomimetic**. It increases the viscosity of tears and prolongs corneal contact time. Cellulose-based polymer β binds to existing tears β stabilizes the aqueous layer of the trilaminar tear film β prevents rapid tear evaporation and provides mechanical lubrication to the cornea and conjunctiva.
λλ¬Ό μ’ λ³ μ©λ
- Keratoconjunctivitis sicca (dry eye) / Ocular lubrication Β· 1-2 drops per affected eye Β· Topical (Ophthalmic) Β· q4h to q12h (or as frequently as needed) Β· Ongoing Β· Frequency depends on the severity of dry eye. May be used as often as every 1-2 hours in severe cases.
- Ocular lubrication (e.g., during anesthesia or for exophthalmos) Β· 1 drop per eye Β· Topical (Ophthalmic) Β· As needed Β· Ongoing Β· Useful to prevent corneal desiccation during anesthesia.
- Ocular lubrication Β· 1-2 drops per affected eye Β· Topical (Ophthalmic) Β· q4h to q12h (or as frequently as needed) Β· Ongoing Β· Frequency depends on the severity of dry eye.
μ©λμ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μ°Έκ³ μλ£μ λλ€. νμ μ΅μ λΌλ²¨κ³Ό κ°λ³ νμμ λν΄ νμΈνμμμ€.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Hypersensitivity to hypromellose or any component of the formulation (such as preservatives like benzalkonium chloride in multi-dose bottles)
μ΄μλ°μ
- Transient blurred vision immediately after application
- Mild ocular irritation or stinging (rare)
- Crusting on the eyelids from dried polymer
μ½λ¬Ό μνΈμμ©
- Other topical ophthalmic medications Β· May wash out other eye drops if administered simultaneously. Hypromellose can also act as a barrier if applied before other drugs. Β· minor
λͺ¨λν°λ§
- Resolution of clinical signs of dry eye (e.g., redness, mucoid discharge, blepharospasm)
- Schirmer Tear Test (STT) if managing KCS
- Corneal staining (fluorescein) to monitor for corneal ulceration secondary to dry eye
κ³Όμ©λ
Overdosage is highly unlikely due to the topical route of administration and lack of systemic absorption. Excess drops will simply overflow from the eye.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.